|
US5227374A
|
|
Lyophilized cyclophosphamide
|
|
US4600758A
|
|
Isoindole derivatives
|
|
US4575555A
|
|
4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
|
|
US4547358A
|
|
Sustained release tablet containing at least 95 percent theophylline
|
|
US4581357A
|
|
Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound
|
|
US4537883A
|
|
Lyophilized cyclophosphamide
|
|
US4505911A
|
|
Isoindole diuretic derivatives, compositions and use
|
|
US4613600A
|
|
Antidepressant 1,2,4-triazolone compounds
|
|
US4524206A
|
|
1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
|
|
US4642345A
|
|
6,7-dihydro-3H-imidazo[1,2-a]-purine-9(4H)-ones
|
|
US4452799A
|
|
Benzisothiazole and benzisoxazole piperazine derivatives
|
|
US4487773A
|
|
1,2,4-Triazol-3-one antidepressants
|
|
US4517188A
|
|
1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
|
|
US4454324A
|
|
Process for production of encainide
|
|
US4438119A
|
|
Method for alleviation of extrapyramidal motor disorders
|
|
US4465660A
|
|
Sustained release tablet containing at least 95 percent theophylline
|
|
US4495194A
|
|
Antihypertensive isoindole derivatives
|
|
US4489078A
|
|
Diazaheterocyclopurines used as anti-broncho spasmatics and vasodilators
|
|
US4463176A
|
|
Process for resolution of optical isomers
|
|
US4417049A
|
|
Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
|
